The prevalence of severe refractory asthma.
Hekking PW, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH.
J Allergy Clin Immunol. 2015 Apr;135(4):896-902. doi: 10.1016/j.jaci.2014.08.042. Epub 2014 Oct 16.
Feline Asthma: Diagnostic and Treatment Update.
Trzil JE.
Vet Clin North Am Small Anim Pract. 2020 Mar;50(2):375-391. doi: 10.1016/j.cvsm.2019.10.002. Epub 2019 Dec 4.
Mepolizumab and exacerbations of refractory eosinophilic asthma.
Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ, Pavord ID.
N Engl J Med. 2009 Mar 5;360(10):973-84. doi: 10.1056/NEJMoa0808991.
Refractory asthma.
McGeehan M, Busse WW.
Med Clin North Am. 2002 Sep;86(5):1073-90. doi: 10.1016/s0025-7125(02)00034-2.
Possible Involvement of Lysophospholipids in Severe Asthma as Novel Lipid Mediators.
Kume H, Kazama K, Sato R, Sato Y.
Biomolecules. 2025 Jan 27;15(2):182. doi: 10.3390/biom15020182.
Refractory asthma: mechanisms, targets, and therapy.
Trevor JL, Deshane JS.
Allergy. 2014 Jul;69(7):817-27. doi: 10.1111/all.12412. Epub 2014 Apr 29.
Refractory neutrophilic asthma and ciliary genes.
Guntur VP, Manka LA, Moore CM, Wynn E, Vladar EK, Alam R, Pham TH, Fingerlin TE, Martin RJ.
J Allergy Clin Immunol. 2022 Jun;149(6):1970-1980. doi: 10.1016/j.jaci.2021.12.761. Epub 2022 Jan 13.
Severe refractory asthma: an update.
Wener RR, Bel EH.
Eur Respir Rev. 2013 Sep 1;22(129):227-35. doi: 10.1183/09059180.00001913.
Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma.
Vincent-Galtié N, Marquant Q, Catherinot E, Ackermann F, Magnan A, Tcherakian C, Groh M.
Respir Res. 2024 Jul 11;25(1):272. doi: 10.1186/s12931-024-02888-x.
Refractory asthma - beyond step 5, the role of new and emerging adjuvant therapies.
Kane B, Fowler SJ, Niven R.
Chron Respir Dis. 2015 Feb;12(1):69-77. doi: 10.1177/1479972314562210. Epub 2014 Dec 9.
